As a prostate cancer survivor, being on active surveillance for 10 years and subsequently robotic surgery, Alan empathises with and empowers men living with a prostate cancer diagnosis.
This has led Alan to be an active consumer advocate at Peter MacCallum Cancer Centre for the last 8 years on the NAVIGATE trial. Along with 3 other major research projects on prostate cancer culminating in the NHMRC funded trial of an online decision aid (DA), NAVIGATE, designed by men for men diagnosed with low risk prostate cancer (LRPC).
In assisting men and their partners, in making management decisions consistent with their values and expectations of the treatments available.
Learn about how the program will:
Increase the uptake of AS being the first line of management option for LRPC
Increase preparedness for decision making
Reduce decisional conflict and regret
Increase decisional satisfaction
Improve the quality of men’s illness
Check out the incredible speaker line-up to see who will be joining Alan.
Unsupported Browser Detected
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.